Building New Zealand's RNA capabilities
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Building New Zealand's RNA capabilities
-
Narrated by:
-
By:
Scientists had long been exploring RNA technology as a way to make vaccines before it had it’s breakout appearance during the Covid-19 pandemic. Since then, interest in the potential uses of RNA to make vaccines and disease treatments has bloomed. In late 2023 a government-funded platform began work to enhance New Zealand’s capacity to design and make RNA. Three years in, how is the platform going?
Sign up to the Our Changing World monthly newsletter for episode backstories, science analysis and more.
Learn more:
- RNA interference (RNAi) technology is being investigated to help honey bees fight off the varroa mite.
- US based Dyne Therapeutics conducted a clinical trial study of their RNA-based therapeutic for myotonic dystrophy in New Zealand.
- Our Changing World covered how the new RNA vaccine tech works in 2021.
- Dr Lisa Connor spoke to RNZ’s health reporter Ruth Hill last August after the US made funding cuts to their RNA vaccine research.
Guests:
- Dr Lisa Connor, Malaghan Institute of Medical Research
- Dr Rebecca McKenzie, Malaghan Institute of Medical Research
Go to this episode on rnz.co.nz for more details
adbl_web_anon_alc_button_suppression_t1
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.